Phase Ib Study for the Combination of Doxorubicin, Dacarbazine, and Nivolumab as the Upfront Treatment in Patients With Advanced Leiomyosarcoma: A Study by the Spanish Sarcoma Group (GEIS) The study ...
A phase 1b study of ruxolitinib (Rux) + gemcitabine (G) ± nab-paclitaxel (N) in patients (pts) with advanced solid tumors.
Two types of weights were created for the analyses found in this report. The first type of weight was designed to ensure each group (e.g., cohort) was individually representative of the general ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results